DrugPatentWatch Database Preview
Otsuka Pharm Co Ltd Company Profile
What is the competitive landscape for OTSUKA PHARM CO LTD, and what generic alternatives to OTSUKA PHARM CO LTD drugs are available?
There are forty-seven US patents protecting OTSUKA PHARM CO LTD drugs.
There are seven hundred and fifteen patent family members on OTSUKA PHARM CO LTD drugs in forty-four countries and fourteen supplementary protection certificates in nine countries.
Summary for Otsuka Pharm Co Ltd
| International Patents: | 715 |
| US Patents: | 47 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Otsuka Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-005 | Nov 13, 2017 | RX | Yes | No | 9,089,567 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Otsuka Pharm Co Ltd | REXULTI | brexpiprazole | TABLET;ORAL | 205422-005 | Jul 10, 2015 | RX | Yes | No | 7,888,362 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-002 | Nov 13, 2017 | RX | Yes | Yes | 9,270,503 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Otsuka Pharm Co Ltd | ABILIFY MYCITE KIT | aripiprazole | TABLET;ORAL | 207202-003 | Nov 13, 2017 | RX | Yes | No | 9,119,554 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Otsuka Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | 5,006,528*PED | ➤ Try a Free Trial |
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-004 | Sep 29, 2014 | 5,006,528*PED | ➤ Try a Free Trial |
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-002 | Feb 28, 2013 | 5,006,528*PED | ➤ Try a Free Trial |
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | 5,006,528*PED | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Otsuka Pharm Co Ltd
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,387,207 | 5-HT1A receptor subtype agonist | ➤ Try a Free Trial |
| 8,545,436 | Body-associated receiver and method | ➤ Try a Free Trial |
| 8,836,513 | Communication system incorporated in an ingestible product | ➤ Try a Free Trial |
| 8,703,772 | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Otsuka Pharm Co Ltd Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 101434575 | ➤ Try a Free Trial |
| Georgia, Republic of | P20074225 | ➤ Try a Free Trial |
| Ukraine | 80802 | ➤ Try a Free Trial |
| Brazil | 0317771 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Otsuka Pharm Co Ltd Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0408 | Netherlands | ➤ Try a Free Trial | 300408, 20101018, EXPIRES: 20151017 |
| /2014 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOL; REGISTRATION NO/DATE: EU/1/13/882 (MITTEILUNG) 20131119 |
| 427 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE |
| 00669 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
